Allena Pharmaceuticals | Evaluate

October 05, 2020

Few clues to flotation fever in past performance

Investors are piling into biotech IPOs, but the track record of previous years' new issues shows how hard it is to pick winners.

January 15, 2018

Tide turns as 2017 IPOs ramp up

Biotechs raised $3.9bn in IPOs across 2017, signalling that investor interest in new issues has returned.

October 12, 2017

Another huge quarter in 2017 for biotech flotations

Another billion dollar quarter for biotech IPOs signals that investor appetite for high-risk offerings is strong.